The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Bayer turns America’s 'Smiths' into aspirin-carrying heart attack heroes

Can Xarelto's trial win in artery disease help J&J keep rival Eliquis at bay?

Teva wraps up Cipro pay-for-delay suit inherited with Barr buy

FiercePharmaAsia: WuXi AppTec subsidiary’s IPO, Mezzion’s lawsuit against Dr. Reddy’s, Eisai’s liver cancer med, and more

Eisai's Lenvima moves toward Nexavar showdown with phase 3 liver cancer win

To win Trump's deal backing, Bayer made a new $8B-plus pledge. But how new is it?

Bayer's struggling Stivarga moves closer to liver-cancer lifeline with FDA 'priority' tag

Ex-VP sues Bayer, saying she defended a pregnant colleague and got whacked for it

Eylea-maker Bayer rolls out diabetic eye disease awareness and advocacy campaign

Bayer blazes new trails for pharma with Betaseron Facebook ad